×
About 47,475 results

ALLMedicine™ Psoriasis Center

Research & Reviews  12,704 results

Psoriasis in the transplant population.
https://doi.org/10.1007/s00403-022-02487-0
Archives of Dermatological Research; Jensen NC, Robins J et. al.

Dec 3rd, 2022 - Solid organ and stem cell transplants are increasingly common, and dermatologists will more frequently encounter and need to manage common skin diseases, such as psoriasis, in transplant patients. This review explores psoriasis remission and occur...

Deucravacitinib in the treatment of psoriasis.
https://doi.org/10.1080/09546634.2022.2154122
The Journal of Dermatological Treatment; Estevinho T, Lé AM et. al.

Dec 2nd, 2022 - Psoriasis is a chronic, immune-mediated, skin disease with a significantly negative impact on patients' quality of life. Moderate-to-severe disease often requires systemic therapies and currently available ones still have numerous disadvantages or...

Female sexual dysfunction in psoriasis: a systematic review and meta-analysis using the...
https://doi.org/10.1038/s41443-022-00650-9
International Journal of Impotence Research; Shah SFH, Merchant SA et. al.

Dec 2nd, 2022 - Psoriasis is an inflammatory skin condition that can negatively affect numerous domains for quality of life, including sexual function. We aimed to systematically compare sexual function between women with and without psoriasis through meta-analys...

Two phenotypes of chronic recurrent multifocal osteomyelitis with different patterns of...
https://doi.org/10.1186/s12969-022-00772-w
Pediatric Rheumatology Online Journal; Cebecauerová D, Malcová H et. al.

Dec 2nd, 2022 - Chronic Recurrent Multifocal Osteomyelitis (CRMO) is an autoinflammatory bone disorder with predominantly paediatric onset. Children present with multifocal osteolytic lesions accompanied by bone pain and soft tissue swelling. Patients often exhib...

Four emerging immune cellular blood phenotypes associated with disease duration and act...
https://doi.org/10.1186/s13075-022-02956-x
Arthritis Research & Therapy; Skougaard M, Ditlev SB et. al.

Nov 30th, 2022 - Psoriatic Arthritis (PsA) is an immune-mediated disease with heterogenous symptoms indicating differences in the underlying immunopathogenesis. The primary objective of the study explored the dynamic mechanisms and interplay between immune cell su...

see more →

Guidelines  25 results

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375973/
Psoriasis (Auckl); Gisondi P, Bellinato F et. al.

Nov 10th, 2022 - Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory arthritis associated with psoriasis, which may manifest with different domains such as dactylitis, enthesitis, synovitis and spondylitis. The estimated prevalence of PsA in patients...

FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older
https://www.arcutis.com/fda-approves-arcutis-zoryve-roflumilast-cream-0-3-for-the-treatment-of-plaque-psoriasis-in-individuals-age-12-and-older/
Arcutis Biotherapeutics, Inc.

Jul 29th, 2022 - WESTLAKE VILLAGE, Calif., July 29, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced today that t...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788316
Journal of the American Academy of Dermatology; Gelfand JM, Armstrong AW et. al.

Jan 11th, 2021 - To update guidance regarding the management of psoriatic disease during the COVID-19 pandemic. The task force (TF) includes 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical ca...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
https://doi.org/10.1159/000512930
Dermatology (Basel, Switzerland); Maul JT, Anzengruber F et. al.

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

see more →

Drugs  1,055 results see all →

Clinicaltrials.gov  1,739 results

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375973/
Psoriasis (Auckl); Gisondi P, Bellinato F et. al.

Nov 10th, 2022 - Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory arthritis associated with psoriasis, which may manifest with different domains such as dactylitis, enthesitis, synovitis and spondylitis. The estimated prevalence of PsA in patients...

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
https://clinicaltrials.gov/ct2/show/NCT04533737

Oct 14th, 2022 - Brodalumab is an anti-interleukin 17 receptor A antibody (IL-17RA) and blocks the inflammatory effects of different IL-17 cytokines (IL-17A, IL-17C, IL-17F, IL-17A/F heterodimer, and IL-17E) in the skin. With increasing availability of novel biolo...

A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
https://clinicaltrials.gov/ct2/show/NCT04435600

Oct 14th, 2022 - Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. There is an unmet medical need for effective treatment in pediatric patients and this study is being do...

A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
https://clinicaltrials.gov/ct2/show/NCT04713072

Oct 14th, 2022 - The ABY-035 drug molecule is a selective inhibitor of interleukin 17A (IL-17A) that binds with high affinity and with a potency corresponding to clinically tested monoclonal antibodies in terms of blocking the biological activity of IL-17A. ABY-03...

Anti-Inflammatory Effects of Time-Restricted Feeding
https://clinicaltrials.gov/ct2/show/NCT04728165

Oct 14th, 2022 - Study Description: Fasting and caloric restriction interventions have anti-inflammatory effects, although the underling regulatory controls are poorly characterized. This pilot study will explore transcriptional profiles in various leukocyte popul...

see more →

News  3,346 results

Breaking the Itch-Scratch Cycle With Mindfulness
https://www.medscape.com/viewarticle/984020

Nov 14th, 2022 - Apple A. Bodemer, MD, a dermatologist at the University of Wisconsin, Madison, teaches patients how to breathe mindfully. So does Kathy Farah, MD, an integrative family physician who practices in Roberts, Wis. Mindful breathing is the most basic m...

Serum Dupilumab Levels Do Not Predict Clinical Response in Adults With Atopic Dermatitis
https://www.medscape.com/viewarticle/983952

Nov 11th, 2022 - The finding that serum dupilumab levels in patients with atopic dermatitis (AD) do not predict long-term response levels or adverse events (AEs) suggests that factors beyond interpatient variability of the interleukin-4 receptor subunit-alpha (IL-...

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375973/
Psoriasis (Auckl); Gisondi P, Bellinato F et. al.

Nov 10th, 2022 - Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory arthritis associated with psoriasis, which may manifest with different domains such as dactylitis, enthesitis, synovitis and spondylitis. The estimated prevalence of PsA in patients...

Morning Stiffness, Dry Eyes, Back Pain in a Fit 58-Year-Old
https://www.medscape.com/viewarticle/983148

Nov 10th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

TNF Inhibitors Linked to Increased Multiple Sclerosis Risk
https://www.medscape.com/viewarticle/983767

Nov 9th, 2022 - Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are associated with an increased risk for multiple sclerosis (MS), especially among patients with rheumatic disease (RD), new research shows. When investigators combed medical databases in fo...

see more →

Patient Education  121 results see all →